Raymond T Chung Selected Research

Lipids

10/2022	Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection.
1/2019	Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
8/2017	Risk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES.
3/2016	A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.
11/2015	Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES.
9/2012	Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.
4/2012	Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus.
10/2009	Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond T Chung Research Topics

Disease

130	Infections 02/2024 - 06/2002
108	Fibrosis (Cirrhosis) 05/2024 - 05/2005
65	Hepatitis C 09/2023 - 12/2003
48	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 11/2003
45	Liver Diseases (Liver Disease) 05/2024 - 05/2005
41	Non-alcoholic Fatty Liver Disease 01/2023 - 06/2012
30	Chronic Hepatitis C 10/2019 - 07/2002
26	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 03/2002
24	Inflammation (Inflammations) 10/2023 - 05/2005
23	Hepatitis B 11/2023 - 03/2004
22	HIV Infections (HIV Infection) 11/2023 - 05/2006
21	Neoplasms (Cancer) 02/2024 - 11/2003
20	Coinfection 01/2023 - 09/2002
15	Chronic Hepatitis B 04/2024 - 03/2004
14	Viremia 06/2023 - 12/2002
14	Virus Diseases (Viral Diseases) 03/2023 - 12/2002
13	End Stage Liver Disease 01/2024 - 06/2007
11	Insulin Resistance 01/2022 - 12/2003
10	Hepatitis 02/2024 - 05/2010
10	Fatty Liver 10/2023 - 01/2013
10	COVID-19 01/2023 - 01/2020
10	Obesity 01/2022 - 08/2009
8	Persistent Infection 01/2021 - 07/2005
7	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 10/2005
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2014
6	Hypertension (High Blood Pressure) 11/2021 - 05/2009
5	Acute Kidney Injury (Acute Renal Failure) 11/2021 - 07/2015
5	Necrosis 11/2021 - 11/2012
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 09/2002
4	Alcoholism (Alcohol Abuse) 01/2023 - 01/2016
4	Hepatic Encephalopathy 01/2022 - 01/2020
4	Carcinogenesis 01/2022 - 01/2013
4	Hemorrhage 12/2020 - 12/2007
4	Chronic Renal Insufficiency 08/2020 - 01/2016
4	Proteinuria 08/2020 - 02/2016
4	Glomerulonephritis 01/2018 - 12/2002
4	Disease Progression 01/2014 - 08/2009
3	Hypoxia (Hypoxemia) 02/2024 - 01/2017

Drug/Important Bio-Agent (IBA)

85	Antiviral Agents (Antivirals)IBA 02/2024 - 12/2003
49	InterferonsIBA 01/2022 - 07/2002
32	RNA (Ribonucleic Acid)IBA 01/2024 - 09/2002
32	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 12/2002
31	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2006
25	Proteins (Proteins, Gene)FDA Link 02/2024 - 12/2002
16	CytokinesIBA 01/2024 - 02/2005
16	Alanine Transaminase (SGPT)IBA 11/2023 - 12/2003
13	Hepatitis B e AntigensIBA 11/2023 - 11/2015
13	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2023 - 09/2012
12	AntigensIBA 11/2023 - 09/2004
12	SofosbuvirIBA 08/2020 - 01/2015
11	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 10/2008
9	Interferon-alpha (Interferon Alfa)IBA 04/2024 - 08/2004
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2015
8	LipidsIBA 10/2022 - 10/2009
8	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2006
7	CreatinineIBA 08/2020 - 11/2012
6	Interleukin-6 (Interleukin 6)IBA 11/2023 - 12/2007
6	VaccinesIBA 01/2023 - 12/2002
6	LigandsIBA 01/2022 - 05/2008
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 04/2016
6	EpitopesIBA 01/2019 - 06/2002
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024 - 12/2018
5	CollagenIBA 01/2023 - 12/2015
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2011
5	EnzymesIBA 01/2022 - 02/2005
5	Peptides (Polypeptides)IBA 01/2022 - 09/2004
5	Interferon LambdaIBA 03/2021 - 04/2014
5	tesamorelin FDA Link 01/2021 - 12/2019
5	CholesterolIBA 01/2021 - 10/2009
5	MicroRNAs (MicroRNA)IBA 01/2018 - 11/2013
5	telaprevirIBA 01/2018 - 09/2010
5	BilirubinIBA 08/2015 - 05/2006
4	Amino Acids FDA Link 10/2023 - 06/2007
4	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2023 - 12/2007
4	Tenofovir (Viread)FDA Link 01/2023 - 03/2004
4	Transaminases (Aminotransferases)IBA 01/2022 - 11/2006
4	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022 - 01/2020
4	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2022 - 01/2013
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 04/2007
4	nasIBA 01/2021 - 08/2015
4	IronIBA 01/2020 - 11/2006
4	sofosbuvir drug combination ledipasvirIBA 01/2019 - 01/2016
4	Protease Inhibitors (Protease Inhibitor)IBA 01/2018 - 09/2010
4	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2018 - 09/2010
4	Small Interfering RNA (siRNA)IBA 11/2016 - 06/2010
4	Epidermal Growth Factor (EGF)IBA 04/2016 - 01/2008
4	Rituximab (Mabthera)FDA Link 12/2015 - 05/2006
4	Interferon alpha-2 (Roferon-A)FDA Link 12/2010 - 12/2002
3	Hepatitis B Core AntigensIBA 06/2023 - 01/2023
3	Interleukin-8 (Interleukin 8)IBA 01/2023 - 04/2007
3	Lipoproteins (Lipoprotein)IBA 10/2022 - 06/2014

Therapy/Procedure

106	Therapeutics 04/2024 - 07/2002
38	Liver Transplantation 05/2024 - 02/2002
8	Transplantation 04/2020 - 07/2013
7	Kidney Transplantation 02/2022 - 02/2002
5	Drug Therapy (Chemotherapy) 02/2024 - 03/2011
4	Chemoprevention 01/2022 - 11/2014
4	Bariatric Surgery 01/2022 - 01/2013
4	Palliative Care (Palliative Therapy) 01/2021 - 01/2019
4	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 09/2002